Autism spectrum disorder in adults: Diagnosis, management, and health services development

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 1669-1686

  Murphy, Clodagh M ^a,b   Ellie Wilson, C ^a,b,c   Robertson, Dene M ^a,b   Ecker, Christine ^a,d   Daly, Eileen M ^a,b   Hammond, Neil ^a,b   Galanopoulos, Anastasios ^a,b   Dud, Lulia ^a,b   Murphy, Declan G ^a,b   McAlonan, Grainne M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SEVILLE   (Spain)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Adults; Autism; Diagnosis; Management; Service development

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; RISPERIDONE;

AGING; ANXIETY; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; COGNITIVE BEHAVIORAL THERAPY; COST EFFECTIVENESS ANALYSIS; DSM-5; DSM-III; DSM-IV; EPILEPSY; EVIDENCE BASED PRACTICE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROINTESTINAL SYMPTOM; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INSOMNIA; LIFESPAN; MENTAL HEALTH CARE; MOOD DISORDER; NEUROCHEMISTRY; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

EID: 84978696456     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S65455     Document Type: Review

References (179)

1. DSM-5. Diagnostic and Statistical Manual of Mental Disorders Washington. Arlington, VA: American Psychiatric Association; 2013.
2. WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993.
3. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011;1380: 138-145.
4. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatry. 2012;57(5): 275-283.
5. Lake JK, Perry A, Lunsky Y. Mental health services for individuals with high functioning autism spectrum disorder. Autism Res Treat. 2014;2014: 502420.
6. Murphy DG, Beecham J, Craig M, Ecker C. Autism in adults. New biologicial findings and their translational implications to the cost of clinical services. Brain Res. 2011;1380: 22-33.
7. Pellicano E, Dinsmore A, Charman T. What should autism research focus upon? Community views and priorities from the United Kingdom. Autism. 2014;18(7): 756-770.
8. Shattuck PT, Roux AM, Hudson LE, Taylor JL, Maenner MJ, Trani JF. Services for adults with an autism spectrum disorder. Can J Psychiatry. 2012;57(5): 284-291.
9. Ecker C, Spooren W, Murphy D. Developing new pharmacotherapies for autism. J Intern Med. 2013;274(4): 308-320.
10. Piven J, Rabins P. Autism-in-Older Adults Working Group. Autism spectrum disorders in older adults: toward defining a research agenda. J Am Geriatr Soc. 2011;59(11): 2151-2155.
11. Asperger H. Die "Autistischen Psychopathen" im Kindesalter. Arch Psychiatr Nervenkr. 1944;117: 76-136.
12. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2: 217-250.
13. Baio J. Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. Surveill Summ. 2012;61(SS03): 1-19.
14. Lotter V. Epidemiology of autistic conditions in young children. Social Psychiatry. 1966;1(3): 124-135.
15. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8): 921-929.
16. Baird G, Simonoff E, Pickles A, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006;368(9531): 210-215.
17. Brugha TS, McManus S, Bankart J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2011;68(5): 459-465.
18. Taylor I. Access to Social Care for Adults with Autism Spectrum Conditions. London: Social Care Institute for Excellence; 2011.
19. Buescher AVS, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014;168(8): 721-728.
20. Cadman T, Eklund H, Howley D, et al. Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United Kingdom. J Am Acad Child Adolesc Psychiatry. 2012;51(9): 879-888.
21. Spain D, Sin J, Chalder T, Murphy D, Happe F. Cognitive behaviour therapy for adults with autism spectrum disorder and psychiatric co-morbidity: a review. Res Autism Spectr Disord. 2015;9: 151-162.
22. Ecker C, Murphy D. Neuroimaging in autism - from basic science to translational research. Nat Rev Neurol. 2014;10(2): 82-91.
23. Gernsbacher MA, Dawson M, Goldsmith HH. Three reasons not to believe in an autism epidemic. Curr Dir Psychol Sci. 2005;14(2): 55-58.
24. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65(6): 591-598.
25. Hansen SN, Schendel DE, Parner ET. Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. JAMA Pediatr. 2015;169(1): 56-62.
26. Lundström S, Reichenberg A, Anckarsäter H, Lichtenstein P, Gillberg C. Autism phenotype versus registered diagnosis in Swedish children: prevalence trends over 10 years in general population samples. BMJ. 2015;350: h1961.
27. United Nations General Assembly. World Autism Awareness Day 2007. New York, NY: United Nations General Assembly; 2007. [No. 62/139 9A/RES/62/139].
28. WHO. Autism Spectrum Disorders and Other Developmental Disorders: From Raising Awareness To Building Capacity 2013. Geneva: WHO; 2013.
29. AutismSpeaks [webpage on the Internet]. Medicines for Treating Autism’s Core Symptoms. Available from: http://www.autismspeaks.org/what-autism/treatment/medicines-treating-core-symptoms. Accessed February 11, 2016.
30. NICE [webpage on the Internet]. Quality Standard 51(QS51): Treating the Core Features of Autism: Medication; 2014. Available from: http://www.nice.org.uk/guidance/qs51/chapter/quality-statement-6-treating-the-core-features-of-autism-medication. Accessed February 11, 2016.
31. Russell AJ, Jassi A, Fullana MA, et al. Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety. 2013;30(8): 697-708.
32. Pellicano E. The development of core cognitive skills in autism: a 3-year prospective study. Child Dev. 2010;81(5): 1400-1416.
33. Bettelheim B. The Empty Fortress: Infantile Autism and the Birth of the Self. New York, NY: Free Press; 1967.
34. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977;18(4): 297-321.
35. Blomquist HK, Bohman M, Edvinsson SO, et al. Frequency of the fragile X syndrome in infantile autism. A Swedish multicenter study. Clin Genet. 1985;27(2): 113-117.
36. Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007;12(1): 2-22.
37. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11): 1095-1102.
38. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry. 2004;61(6): 618-627.
39. Maramara LA, He W, Ming X. Pre- and perinatal risk factors for autism spectrum disorder in a New Jersey cohort. J Child Neurol. 2014;29(12): 1645-1651.
40. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics. 2011;128(2): 344-355.
41. Guinchat V, Thorsen P, Laurent C, Cans C, Bodeau N, Cohen D. Pre-, peri- and neonatal risk factors for autism. Acta Obstet Gynecol Scand. 2012;91(3): 287-300.
42. Froehlich-Santino W, Londono Tobon A, Cleveland S, et al. Prenatal and perinatal risk factors in a twin study of autism spectrum disorders. J Psychiatr Res. 2014;54: 100-108.
43. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry. 2011;16(12): 1203-1212.
44. Reichenberg A, Gross R, Weiser M, et al. Advancing paternal age and autism. Arch Gen Psychiatry. 2006;63(9): 1026-1032.
45. Simonoff E. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord. 1998;28(5): 447-456.
46. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008;9(5): 341-355.
47. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry. 2010;19(3): 169-178.
48. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66(suppl 10): 3-8.
49. Werling DM, Geschwind DH. Sex differences in autism spectrum disorders. Curr Opin Neurol. 2013;26(2): 146-153.
50. Craig MC, Zaman SH, Daly EM, et al. Women with autistic-spectrum disorder: magnetic resonance imaging study of brain anatomy. Br J Psychiatry. 2007;191: 224-228.
51. Lai MC, Lombardo MV, Suckling J, et al. Biological sex affects the neurobiology of autism. Brain. 2013;136(pt 9): 2799-2815.
52. Schaer M, Kochalka J, Padmanabhan A, Supekar K, Menon V. Sex differences in cortical volume and gyrification in autism. Mol Autism. 2015;6: 42.
53. Tropeano M, Howley D, Gazzellone MJ, et al. Microduplications at the pseudoautosomal SHOX locus in autism spectrum disorders and related neurodevelopmental conditions. J Med Genet. Epub 2016 Apr 12.
54. Wilson C, Murphy CM, McAlonan G, et al. Does sex influence the diagnostic evaluation of autism spectrum disorder in adults? Autism. Epub 2016 Jan 22.
55. Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015;54(1): 11-24.
56. GOV.UK [webpage on the Internet]. Think Autism. Available from: www.gov.uk/government/publications/think-autism-an-update-to-the-government-adult-autism-strategy. Accessed February 11, 2016.
57. D’Astous V, Manthorpe J, Lowton K, Glaser K. Historical social care context of autism: a narrative overview. Br J Soc Work. 2014: 1-19.
58. Ecker C, Bookheimer SY, Murphy DG. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 2015;14: 1121-1134.
59. Lord CE. Autism: from research to practice. Am Psychol. 2010;65(8): 815-826.
60. Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31(3): 137-145.
61. Ashwood KL, Buitelaar J, Murphy D, Spooren W, Charman T. European clinical network: autism spectrum disorder assessments and patient characterisation. Eur Child Adolesc Psychiatry. 2015;24(8): 985-995.
62. Lord C, Jones RM. Annual research review: re-thinking the classification of autism spectrum disorders. J Child Psychol Psychiatry. 2012;53(5): 490-509.
63. Asperger H. Die "Autistischen Psychopathen" im Kindesalter. Arch Psychiatr Nervenkr. 1943;117: 76-136.
64. Frith U. Translation and annotation of "autistic psychopathy" in childhood. In: Asperger H, editor.. Autism and Asperger Syndrome. Cambridge: Cambridge University Press; 1991: 37-92.
65. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: APA; 1980.
66. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA; 2000.
67. Young S, Murphy CM, Coghill D. Avoiding the ‘twilight zone’: recommendations for the transition of services from adolescence to adulthood for young people with ADHD. BMC Psychiatry. 2011;11: 174.
68. Huerta M, Bishop SL, Duncan A, Hus V, Lord C. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders. Am J Psychiatry. 2012;169(10): 1056-1064.
69. Wilson CE, Gillan N, Spain D, et al. Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult autism spectrum disorder diagnostic clinic. J Autism Dev Disord. 2013;43(11): 2515-2525.
70. McAlonan GM, Cheung C, Cheung V, Wong N, Suckling J, Chua SE. Differential effects on white-matter systems in high-functioning autism and Asperger’s syndrome. Psychol Med. 2009;39(11): 1885-1893.
71. McAlonan GM, Suckling J, Wong N, et al. Distinct patterns of grey matter abnormality in high-functioning autism and Asperger’s syndrome. J Child Psychol Psychiatry. 2008;49(12): 1287-1295.
72. Yu KK, Cheung C, Chua SE, McAlonan GM. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J Psychiatry Neurosci. 2011;36(6): 412-421.
73. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for research. Geneva: World Health Organization; 1993.
74. Croen LA, Zerbo O, Qian Y, et al. The health status of adults on the autism spectrum. Autism. 2015;19(7): 814-823.
75. Fortuna RJ, Robinson L, Smith TH, et al. Health conditions and functional status in adults with autism: a cross-sectional evaluation. J Gen Intern Med. 2016;31(1): 77-84.
76. Tyler CV, Schramm SC, Karafa M, Tang AS, Jain AK. Chronic disease risks in young adults with autism spectrum disorder: forewarned is forearmed. Am J Intellect Dev Disabil. 2011;116(5): 371-380.
77. Nicolaidis C, Raymaker D, McDonald K, et al. Comparison of healthcare experiences in autistic and non-autistic adults: a cross-sectional online survey facilitated by an academic-community partnership. J Gen Intern Med. 2013;28(6): 761-769.
78. Zerbo O, Massolo ML, Qian Y, Croen LA. A study of physician knowledge and experience with autism in adults in a large integrated healthcare system. J Autism Dev Disord. 2015;45(12): 4002-4014.
79. Nicolaidis C, Raymaker DM, Ashkenazy E, et al. "Respect the way I need to communicate with you": healthcare experiences of adults on the autism spectrum. Autism. 2015;19(7): 824-831.
80. Cohen S, Conduit R, Lockley SW, Rajaratnam SM, Cornish KM. The relationship between sleep and behavior in autism spectrum disorder (ASD): a review. J Neurodev Disord. 2014;6(1): 44.
81. Richdale AL, Schreck KA. Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies. Sleep Med Rev. 2009;13(6): 403-411.
82. Baker EK, Richdale AL. Sleep patterns in adults with a diagnosis of high-functioning autism spectrum disorder. Sleep. 2015;38(11): 1765-1774.
83. Tani P, Lindberg N, Nieminen-von Wendt T, et al. Sleep in young adults with Asperger syndrome. Neuropsychobiology. 2004;50(2): 147-152.
84. Limoges E, Mottron L, Bolduc C, Berthiaume C, Godbout R. Atypical sleep architecture and the autism phenotype. Brain. 2005;128(pt 5): 1049-1061.
85. Malow BA, Byars K, Johnson K, et al; Sleep Committee of the Autism Treatment Network. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130(suppl 2): S106-S124.
86. Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011;32(3): 939-962.
87. Buie T, Campbell DB, Fuchs GJ 3rd, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(suppl 1): S1-S18.
88. McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133(5): 872-883.
89. Furuta GT, Williams K, Kooros K, et al. Management of constipation in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130(suppl 2): S98-S105.
90. Sharp WG, Berry RC, McCracken C, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature. J Autism Dev Disord. 2013;43(9): 2159-2173.
91. Berry RC, Novak P, Withrow N, et al. Nutrition management of gastrointestinal symptoms in children with autism spectrum disorder: guideline from an expert panel. J Acad Nutr Diet. 2015;115(12): 1919-1927.
92. Elder JH, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L. The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord. 2006;36(3): 413-420.
93. Kirby M, Danner E. Nutritional deficiencies in children on restricted diets. Pediatr Clin North Am. 2009;56(5): 1085-1103.
94. El Achkar CM, Spence SJ. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy Behav. 2015;47: 183-190.
95. Reilly C, Atkinson P, Das KB, et al. Features of autism spectrum disorder (ASD) in childhood epilepsy: a population-based study. Epilepsy Behav. 2015;42: 86-92.
96. Accardo JA, Malow BA. Sleep, epilepsy, and autism. Epilepsy Behav. 2015;47: 202-206.
97. Frye RE. Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 2015;47: 147-157.
98. Hofvander B, Delorme R, Chaste P, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry. 2009;9: 35.
99. Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 2011;32(5): 1910-1917.
100. Russell AJ, Mataix-Cols D, Anson M, Murphy DG. Obsessions and compulsions in Asperger syndrome and high-functioning autism. Br J Psychiatry. 2005;186: 525-528.
101. Johnston K, Dittner A, Bramham J, Murphy C, Knight A, Russell A. Attention deficit hyperactivity disorder symptoms in adults with autism spectrum disorders. Autism Res. 2013;6(4): 225-236.
102. Simonoff E, Jones CR, Baird G, Pickles A, Happé F, Charman T. The persistence and stability of psychiatric problems in adolescents with autism spectrum disorders. J Child Psychol Psychiatry. 2013;54(2): 186-194.
103. Russell A, Murphy CM, Wilson CE, et al. The mental health of individuals referred for assessment of autism spectrum disorder (ASD) in adulthood: a clinic report. Autism. Epub 2015 Oct 15.
104. Hill EL. Executive dysfunction in autism. Trends Cogn Sci. 2004;8(1): 26-32.
105. Luke L, Clare IC, Ring H, Redley M, Watson P. Decision-making difficulties experienced by adults with autism spectrum conditions. Autism. 2012;16(6): 612-621.
106. Rommelse NN, Geurts HM, Franke B, Buitelaar JK, Hartman CA. A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes. Neurosci Biobehav Rev. 2011;35(6): 1363-1396.
107. Wilson CE, Happe F, Wheelwright SJ, et al; Sauter DA; MRC AIMS Consortium. The neuropsychology of male adults with high-functioning autism or asperger syndrome. Autism Res. 2014;7(5): 568-581.
108. Green J, Gilchrist A, Burton D, Cox A. Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. J Autism Dev Disord. 2000;30(4): 279-293.
109. Corbett BA, Constantine LJ, Hendren R, Rocke D, Ozonoff S. Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development. Psychiatry Res. 2009;166(2-3): 210-222.
110. Schatz AM, Weimer AK, Trauner DA. Brief report: attention differences in Asperger syndrome. J Autism Dev Disord. 2002;32(4): 333-336.
111. Sturm H, Fernell E, Gillberg C. Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups. Dev Med Child Neurol. 2004;46(7): 444-447.
112. Allen G, Courchesne E. Attention function and dysfunction in autism. Front Biosci. 2001;6: D105-D119.
113. Taurines R, Schwenck C, Westerwald E, Sachse M, Siniatchkin M, Freitag C. ADHD and autism: differential diagnosis or overlapping traits? A selective review. Atten Defic Hyperact Disord. 2012;4(3): 115-139.
114. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child. 2006;32(5): 575-583.
115. Ghanizadeh A. Atomoxetine for treating ADHD symptoms in autism: a systematic review. J Atten Disord. 2013;17(8): 635-640.
116. Reiersen AM, Todd RD. Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Rev Neurother. 2008;8(4): 657-669.
117. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11): 1266-1274.
118. Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2): 180-187.
119. Mahajan R, Bernal MP, Panzer R, et al; Autism Speaks Autism Treatment Network Psychopharmacology Committee. Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics. 2012;130(Suppl 2): S125-S138.
120. Christakou A, Murphy CM, Chantiluke K, et al. Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Mol Psychiatry. 2013;18(2): 236-244.
121. Chantiluke K, Christakou A, Murphy CM, et al. Disorder-specific functional abnormalities during temporal discounting in youth with attention deficit hyperactivity disorder (ADHD), Autism and comorbid ADHD and autism. Psychiatry Res. 2014;223(2): 113-120.
122. Bakken TL, Helverschou SB, Eilertsen DE, et al. Psychiatric disorders in adolescents and adults with autism and intellectual disability: a representative study in one county in Norway. Res Dev Disabil. 2010;31(6): 1669-1677.
123. Cadman T, Spain D, Johnston P, et al. Obsessive-compulsive disorder in adults with high-functioning autism spectrum disorder: what does self-report with the OCI-R tell us? Autism Res. 2015;8(5): 477-485.
124. Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11): 858-866.
125. Russell AJ, Mataix-Cols D, Anson MA, Murphy DG. Psychological treatment for obsessive-compulsive disorder in people with autism spectrum disorders - a pilot study. Psychother Psychosom. 2009; 78(1): 59-61.
126. NICE [webpage on the Internet]. National Institute for Health and Care Excellence (NICE) Guidelines for the Care of Adults with ASD. Available from: www.nice.org.uk/guidance/cg142. Accessed February 11, 2016.
127. Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5): 659-685.
128. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30(3): 205-223.
129. Jones RM, Lord C. Diagnosing autism in neurobiological research studies. Behav Brain Res. 2013;251: 113-124.
130. Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4): 427-433.
131. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry. 2005;57(6): 655-660.
132. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1): 5-17.
133. Ashwood KL, Gillan N, Horder J, et al. Predicting the diagnosis of autism in adults using the Autism-Spectrum Quotient (AQ) Questionnaire. Psychological Medicine. In Press.
134. Bassett AS, McDonald-McGinn DM, Devriendt K, et al; International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2): 332e1-339e1.
135. Ecker C, Rocha-Rego V, Johnston P, et al; MRC AIMS Consortium. Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach. Neuroimage. 2010;49(1): 44-56.
136. Broadstock M, Doughty C, Eggleston M. Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder. Autism. 2007;11(4): 335-348.
137. Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. J Autism Dev Disord. 2009;39(9): 1339-1349.
138. Murray ML, Hsia Y, Glaser K, et al. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology. 2014;231(6): 1011-1021.
139. Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC. Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology. 2014;231(6): 999-1009.
140. Wong AY, Hsia Y, Chan EW, et al. The variation of psychopharmacological prescription rates for people with autism spectrum disorder (ASD) in 30 countries. Autism Res. 2014;7(5): 543-554.
141. Steckler T, Spooren W, Murphy D. Autism spectrum disorders - an emerging area in psychopharmacology. Psychopharmacology. 2014;231(6): 977-978.
142. Murphy D, Spooren W. EU-AIMS: a boost to autism research. Nat Rev Drug Discov. 2012;11(11): 815-816.
143. Bishop-Fitzpatrick L, Minshew NJ, Eack SM. A systematic review of psychosocial interventions for adults with autism spectrum disorders. J Autism Dev Disord. 2013;43(3): 687-694.
144. Spek AA, van Ham NC, Nyklíček I. Mindfulness-based therapy in adults with an autism spectrum disorder: a randomized controlled trial. Res Dev Disabil. 2013;34(1): 246-253.
145. Hesselmark E, Plenty S, Bejerot S. Group cognitive behavioural therapy and group recreational activity for adults with autism spectrum disorders: a preliminary randomized controlled trial. Autism. 2013;18(6): 672-683.
146. Eack SM, Greenwald DP, Hogarty SS, et al. Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study. J Autism Dev Disord. 2013;43(12): 2866-2877.
147. NICE. Guidelines Including Transition Recommendations. Available from: www.nice.org.uk/guidance/cg170/resources/guidance-autism NICE 2012.
148. Cheak-Zamora NC, Yang X, Farmer JE, Clark M. Disparities in transition planning for youth with autism spectrum disorder. Pediatrics. 2013;131(3): 447-454.
149. Stewart D. Transition to adult services for young people with disabilities: current evidence to guide future research. Dev Med Child Neurol. 2009;51(Suppl 4): 169-173.
150. Belling R, McLaren S, Paul M, et al. The effect of organisational resources and eligibility issues on transition from child and adolescent to adult mental health services. J Health Serv Res Policy. 2014;19(3): 169-176.
151. American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110(6 pt 2): 1304-1306.
152. Taylor JL, Henninger NA. Frequency and correlates of service access among youth with autism transitioning to adulthood. J Autism Dev Disord. 2015;45(1): 179-191.
153. Happé F, Charlton RA. Aging in autism spectrum disorders: a mini-review. Gerontology. 2012;58(1): 70-78.
154. Starkstein S, Gellar S, Parlier M, Payne L, Piven J. High rates of parkinsonism in adults with autism. J Neurodev Disord. 2015;7(1): 29.
155. Coppus A, Evenhuis H, Verberne GJ, van Gool P, Eikelenboom P, van Duijin C. Dementia and mortality in persons with Down’s syndrome. J Intellect Disabil Res. 2006;50(Pt 10): 768-777.
156. Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging. Am J Med Genet A. 2010;152A(11): 2937-2938.
157. Butcher NJ, Kiehl TR, Hazrati LN, et al. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol. 2013;70(11): 1359-1366.
158. Lainhart JE. Brain imaging research in autism spectrum disorders: in search of neuropathology and health across the lifespan. Curr Opin Psychiatry. 2015;28(2): 76-82.
159. Carper RA, Moses P, Tigue ZD, Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage. 2002;16(4): 1038-1051.
160. Hazlett HC, Poe MD, Gerig G, et al. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry. 2011;68(5): 467-476.
161. Schumann CM, Bloss CS, Barnes CC, et al. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci. 2010;30(12): 4419-4427.
162. Hardan AY, Libove RA, Keshavan MS, Melhem NM, Minshew NJ. A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry. 2009;66(4): 320-326.
163. Murphy CM, Deeley Q, Daly EM, et al. Anatomy and aging of the amygdala and hippocampus in autism spectrum disorder: an in vivo magnetic resonance imaging study of Asperger syndrome. Autism Res. 2012;5(1): 3-12.
164. Langen M, Schnack HG, Nederveen H, et al. Changes in the developmental trajectories of striatum in autism. Biol Psychiatry. 2009;66(4): 327-333.
165. Ecker C, Shahidiani A, Feng Y, et al. The effect of age, diagnosis, and their interaction on vertex-based measures of cortical thickness and surface area in autism spectrum disorder. J Neural Transm. 2014;121(9): 1157-1170.
166. Wallace GL, Dankner N, Kenworthy L, Giedd JN, Martin A. Age-related temporal and parietal cortical thinning in autism spectrum disorders. Brain. 2010;133(Pt 12): 3745-3754.
167. Fidler DJ, Bailey JN, Smalley SL. Macrocephaly in autism and other pervasive developmental disorders. Dev Med Child Neurol. 2000;42(11): 737-740.
168. Raznahan A, Wallace GL, Antezana L, et al. Compared to what? Early brain overgrowth in autism and the perils of population norms. Biol Psychiatry. 2013;74(8): 563-575.
169. Campbell DJ, Chang J, Chawarska K. Early generalized overgrowth in autism spectrum disorder: prevalence rates, gender effects, and clinical outcomes. J Am Acad Child Adolesc Psychiatry. 2014;53(10): 1063e5-1073e5.
170. Murphy CM, Christakou A, Daly EM, et al. Abnormal functional activation and maturation of fronto-striato-temporal and cerebellar regions during sustained attention in autism spectrum disorder. Am J Psychiatry. 2014;171(10): 1107-1116.
171. Mendez MA, Horder J, Myers J, et al. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology. 2013;68: 195-201.
172. Daly E, Ecker C, Hallahan B, et al. Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion. Brain. 2014;137(Pt 9): 2600-2610.
173. Daly EM, Deeley Q, Ecker C, et al. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch Gen Psychiatry. 2012;69(10): 1003-1013.
174. Nakamura K, Sekine Y, Ouchi Y, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67(1): 59-68.
175. Guastella AJ, Hickie IB. Oxytocin treatment, circuitry and autism: a critical review of the literature placing oxytocin into the autism context. Biol Psychiatry. 2016;79(3): 234-242.
176. Anagnostou E, Soorya L, Chaplin W, et al. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012;3(1): 16.
177. Anagnostou E, Soorya L, Brian J, et al. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res. 2014;1580: 188-198.
178. ICD-10. World Health Organization. International Classification of Diseases: Diagnostic Criteria for Research. 10th ed. Geneva: World Health Organization; 1992.
179. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.